- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Asset Management One Boosts AbbVie Stake by 4.5%
The institutional investor now owns over 900,000 shares of the pharmaceutical giant.
Apr. 18, 2026 at 7:08am
Got story updates? Submit your updates here. ›
The intricate financial machinery behind major pharmaceutical investments reflects the institutional forces shaping the healthcare industry.North Chicago TodayAsset Management One Co. Ltd. increased its holdings in AbbVie Inc. (NYSE:ABBV) by 4.5% in the fourth quarter, according to a recent SEC filing. The firm now owns 909,250 shares of the company's stock, valued at over $209 million.
Why it matters
AbbVie is a major pharmaceutical company with a diverse product portfolio spanning immunology, oncology, neuroscience, and other therapeutic areas. Institutional investors closely monitor ownership changes in large-cap healthcare stocks like AbbVie as they can signal broader market trends and investor sentiment.
The details
According to the 13F filing, Asset Management One added 39,118 shares of AbbVie to its portfolio during the fourth quarter. The firm's total AbbVie position now represents about 0.6% of its overall assets under management.
- Asset Management One filed the 13F report disclosing the AbbVie stake increase on April 18, 2026.
- The reported activity occurred during the fourth quarter of 2025.
The players
Asset Management One Co. Ltd.
A Japanese asset management firm that oversees over $1 trillion in client assets globally.
AbbVie Inc.
A global biopharmaceutical company focused on developing and commercializing specialty medicines across immunology, oncology, neuroscience, and other therapeutic areas.
The takeaway
The increased stake by Asset Management One underscores the continued institutional investor interest in AbbVie as the company navigates patent expirations and pipeline development for its key drug franchises.
